| 000 | 01300 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514155339.0 | ||
| 264 | 0 | _c20031125 | |
| 008 | 200311s 0 0 fre d | ||
| 022 | _a0929-693X | ||
| 024 | 7 |
_a10.1016/s0929-693x(03)90394-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTauber, M | |
| 245 | 0 | 0 |
_a[Management of recombinant growth hormone treatment in Prader-Willi syndrome]. _h[electronic resource] |
| 260 |
_bArchives de pediatrie : organe officiel de la Societe francaise de pediatrie _cMay 2003 |
||
| 300 |
_a90s-91s p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 |
_aHuman Growth Hormone _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aPrader-Willi Syndrome _xcomplications |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 773 | 0 |
_tArchives de pediatrie : organe officiel de la Societe francaise de pediatrie _gvol. 10 Suppl 1 _gp. 90s-91s |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0929-693x(03)90394-0 _zAvailable from publisher's website |
| 999 |
_c14270610 _d14270610 |
||